{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:52:59Z","timestamp":1791910379083,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118305","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:58:55Z","timestamp":1785538735000},"page":"118305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["HECW2 suppresses non-small cell lung cancer progression by destabilizing SCNN1A and inactivating AKT\/mTOR pathway"],"prefix":"10.1016","volume":"253","author":[{"given":"Lan","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2026.118305_b0005","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3390\/ijms26052049","article-title":"Lung cancer-epidemiology, pathogenesis, treatment and molecular aspect (review of literature)","volume":"26","author":"Smolarz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118305_b0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-025-02245-6","article-title":"Traditional Chinese medicine in lung cancer treatment","volume":"24","author":"Xi","year":"2025","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2026.118305_b0015","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.bcp.2026.118305_b0020","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1080\/15384101.2022.2071565","article-title":"CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5","volume":"22","author":"Luo","year":"2023","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.bcp.2026.118305_b0025","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13046-023-02916-6","article-title":"Circular RNA circATP9A promotes non-small cell lung cancer progression by interacting with HuR and by promoting extracellular vesicles-mediated macrophage M2 polarization","volume":"42","author":"Yao","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118305_b0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-022-01391-4","article-title":"Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance","volume":"15","author":"Fu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118305_b0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-024-01581-2","article-title":"Dual blockade immunotherapy targeting PD-1\/PD-L1 and CTLA-4 in lung cancer","volume":"17","author":"Cheng","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118305_b0040","first-page":"620","article-title":"Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions","volume":"73","author":"Megyesfalvi","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.bcp.2026.118305_b0045","article-title":"Single-Cell transcriptome identifies drug-resistance signature and immunosuppressive microenvironment in metastatic small cell lung cancer","volume":"3","author":"Zhang","year":"2022","journal-title":"Adv. Genet. (Hoboken)."},{"issue":"1","key":"10.1016\/j.bcp.2026.118305_b0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41418-023-01239-5","article-title":"TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11\/xCT K11-linked ubiquitination and degradation","volume":"31","author":"Wang","year":"2024","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.bcp.2026.118305_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2021.151818","article-title":"E3 ubiquitin-protein ligase 2 inhibits cell proliferation, migration, and invasion of non-small cell lung cancer through ubiquitination of Notch1","volume":"124","author":"Guo","year":"2022","journal-title":"Acta Histochem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118305_b0060","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/s41467-024-45635-y","article-title":"Structure-guided engineering enables E3 ligase-free and versatile protein ubiquitination via UBE2E1","volume":"15","author":"Wu","year":"2024","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bcp.2026.118305_b0065","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s12272-020-01281-8","article-title":"Ubiquitin-proteasome system (UPS) as a target for anticancer treatment","volume":"43","author":"Park","year":"2020","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bcp.2026.118305_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122333","article-title":"E3 ubiquitin ligases in lung cancer: Emerging insights and therapeutic opportunities","volume":"336","author":"Basu","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.118305_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156001","article-title":"Exploiting E3 ligases for lung cancer therapy: the promise of DCAF-PROTACs","volume":"270","author":"Hussain","year":"2025","journal-title":"Pathol. Res. Pract."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2026.118305_b0080","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10495-022-01789-y","article-title":"Tumor-suppressive E3 ubiquitin ligase CHIP inhibits the PBK\/ERK axis to repress stem cell properties and radioresistance in non-small cell lung cancer","volume":"28","author":"Tan","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2026.118305_b0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2021.03.137","article-title":"E3 ubiquitin ligase PJA1 regulates lung adenocarcinoma apoptosis and invasion through promoting FOXR2 degradation","volume":"556","author":"Luo","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118305_b0090","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12935-024-03563-3","article-title":"E3 ubiquitin ligase HECW2: a promising target for tumour therapy","volume":"24","author":"Shen","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"7","key":"10.1016\/j.bcp.2026.118305_b0095","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/jmedgenet-2021-107871","article-title":"Delineating the genotypic and phenotypic spectrum of HECW2-related neurodevelopmental disorders","volume":"59","author":"Acharya","year":"2022","journal-title":"J. Med. Genet."},{"issue":"6","key":"10.1016\/j.bcp.2026.118305_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2022.104515","article-title":"A homozygous nonsense HECW2 variant is associated with neurodevelopmental delay and intellectual disability","volume":"65","author":"Krami","year":"2022","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.bcp.2026.118305_b0105","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6284960","article-title":"Genome-wide profiling of human papillomavirus DNA integration into human genome and its influence on PD-L1 expression in Chinese Uygur cervical cancer women","volume":"2020","author":"Yang-Chun","year":"2020","journal-title":"J. Immunol. Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.118305_b0110","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.62347\/OKZH4183","article-title":"HECW2 knockdown suppresses the development of infantile hemangioma by inhibiting ALKBH5\/LDHA axis-mediated glycolysis","volume":"15","author":"Peng","year":"2025","journal-title":"Am. J. Cancer Res."},{"issue":"15","key":"10.1016\/j.bcp.2026.118305_b0115","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.7150\/jca.87545","article-title":"HECW2 promotes the progression and chemoresistance of colorectal cancer via AKT\/mTOR signaling activation by mediating the ubiquitin-proteasome degradation of lamin B1","volume":"14","author":"Li","year":"2023","journal-title":"J. Cancer"},{"issue":"D1","key":"10.1016\/j.bcp.2026.118305_b0120","doi-asserted-by":"crossref","first-page":"D719","DOI":"10.1093\/nar\/gkab962","article-title":"UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase\/deubiquitinase-substrate interactions in eukaryotic species","volume":"50","author":"Wang","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118305_b0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00439-006-0140-2","article-title":"The TNFalpha receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis","volume":"119","author":"Stanke","year":"2006","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bcp.2026.118305_b0130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2407-11-66","article-title":"Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma","volume":"11","author":"Car\u00e9n","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2026.118305_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2022.109323","article-title":"Sodium channel 1 subunit alpha SCNN1A exerts oncogenic function in pancreatic cancer via accelerating cellular growth and metastasis","volume":"727","author":"Gao","year":"2022","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.bcp.2026.118305_b0140","first-page":"1429","article-title":"miR\u201195 promotes osteosarcoma growth by targeting SCNN1A","volume":"43","author":"Geng","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcp.2026.118305_b0145","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2147\/IJGM.S351976","article-title":"SCNN1A overexpression correlates with poor prognosis and immune infiltrates in ovarian cancer","volume":"15","author":"Lou","year":"2022","journal-title":"Int. J. Gen. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.118305_b0150","doi-asserted-by":"crossref","first-page":"9390","DOI":"10.1080\/21655979.2021.1978615","volume":"12","author":"Cai","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.bcp.2026.118305_b0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The gene expression omnibus database","volume":"1418","author":"Clough","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118305_b0160","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1016\/j.cellsig.2014.09.014","article-title":"Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis","volume":"26","author":"Wei","year":"2014","journal-title":"Cell. Signal."},{"issue":"13","key":"10.1016\/j.bcp.2026.118305_b0165","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1158\/1078-0432.CCR-13-0341","article-title":"ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer","volume":"19","author":"Kabbout","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118305_b0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13104-015-1053-8","article-title":"Identification of regulatory SNPs associated with genetic modifications in lung adenocarcinoma","volume":"8","author":"Lu","year":"2015","journal-title":"BMC. Res. Notes"},{"issue":"4","key":"10.1016\/j.bcp.2026.118305_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010312","article-title":"Gene expression-based classification of non-small cell lung carcinomas and survival prediction","volume":"5","author":"Hou","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bcp.2026.118305_b0180","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/s41418-024-01357-8","article-title":"The PRMT6\/STAT1\/ACSL1 axis promotes ferroptosis in diabetic nephropathy","volume":"31","author":"Hong","year":"2024","journal-title":"Cell Death Differ."},{"issue":"183","key":"10.1016\/j.bcp.2026.118305_b0185","doi-asserted-by":"crossref","first-page":"666","DOI":"10.24976\/Discov.Med.202436183.63","article-title":"Epithelial-mesenchymal transformation promotes the progression of hepatocellular carcinoma through NF-\u03baB\/MMP9 axis","volume":"36","author":"Li","year":"2024","journal-title":"Discov. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.118305_b0190","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/med.21948","article-title":"Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds","volume":"43","author":"Ang","year":"2023","journal-title":"Med. Res. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2026.118305_b0195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.31083\/j.fbl2904140","article-title":"CD146 promotes EMT-mediated migration and invasion of NSCLC via PI3K\/Akt signaling pathway","volume":"29","author":"Wei","year":"2024","journal-title":"Front .Biosci. (Landmark Ed)."},{"issue":"10","key":"10.1016\/j.bcp.2026.118305_b0200","first-page":"642","article-title":"Upregulation of SCNN1A promotes cell proliferation, migration, and predicts poor prognosis in ovarian cancer through regulating epithelial-mesenchymal transformation","volume":"34","author":"Wu","year":"2019","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.bcp.2026.118305_b0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118305_b0210","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2026.118305_b0215","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/1759-7714.13328","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC)","volume":"11","author":"Tan","year":"2020","journal-title":"Thorac Cancer."},{"issue":"4","key":"10.1016\/j.bcp.2026.118305_b0220","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/10409238.2012.678285","article-title":"Organization of the ENaC-regulatory machinery","volume":"47","author":"Soundararajan","year":"2012","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118305_b0225","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12931-020-01595-7","article-title":"Bone marrow mesenchymal stem cells derived miRNA-130b enhances epithelial sodium channel by targeting PTEN","volume":"21","author":"Zhang","year":"2020","journal-title":"Respir. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:24:42Z","timestamp":1791908682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":45,"alternative-id":["S0006295226006441"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118305","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HECW2 suppresses non-small cell lung cancer progression by destabilizing SCNN1A and inactivating AKT\/mTOR pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118305"}}